
Request Appointment
525 E 68th St# M404New York, NY 10065
Fax+1 646-962-0203
Overview of Dr. Lee
Dr. Benjamin Lee is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Queens. He received his medical degree from New York Medical College and has been in practice 15 years. He is one of 27 doctors at New York-Presbyterian Queens and one of 149 doctors at New York-Presbyterian Hospital who specialize in Thoracic Surgery. He has more than 50 publications and over 500 citings.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Thoracic Surgery - Independent, 2007 - 2009
- University of California Davis HealthResidency, Surgery, 2001 - 2007
- New York Medical CollegeClass of 2001
Certifications & Licensure
- CA State Medical License 2003 - Present
- NY State Medical License 2007 - 2026
- FL State Medical License 2017 - 2019
- NJ State Medical License 2009 - 2017
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Clinical Trials
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Start of enrollment: 2007 Oct 12
Publications & Presentations
PubMed
- 2 citationsEvaluating ChatGPT as a patient resource for frequently asked questions about lung cancer surgery-a pilot study.Dana Ferrari-Light, Robert E Merritt, Desmond D'Souza, Mark K Ferguson, Sebron Harrison
The Journal of Thoracic and Cardiovascular Surgery. 2025-04-01 - Reducing Local Recurrence After Sublobar Resection: Not As Easy As It Seems.Nasser Altorki, Benjamin E Lee
Journal of Thoracic Oncology. 2025-02-01 - 1 citationsReporting Minority Race and Ethnicity in Cardiovascular and Thoracic Journals.Shahenda Khedr, Julie Hong, Ninon Forter-Chee-A-Tow, Gala Cygiel, Daithi S Heffernan
The Journal of Surgical Research. 2024-09-01
Press Mentions
- Surgical Resection After Neoadjuvant Durvalumab and Radiation Is Feasible and Safe in Non-Small Cell Lung Cancer: Results from a Randomized TrialMay 17th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: